AVEO Oncology

08/10/2026

Thank you to our Research Sponsors: Natera, AVEO Oncology, and Pfizer!

Your support helps make KCRS a place where innovative ideas are shared, new collaborations are formed, and the latest advances in research take center stage.

We are so grateful for your commitment to supporting the scientific community and helping for people affected by kidney cancer.

08/10/2026

The AVEO Oncology, an LG Chem company, team recently attended the American Head and Neck Society - AHNS 12th International Conference in Boston. Thank you to the AHNS for providing an important forum for clinicians, researchers and industry professionals from around the world to share the latest advances in the prevention, diagnosis and treatment of head and neck cancers. Learn more about AVEO’s ongoing research in head and neck cancer by visiting www.fiercehn.com

07/22/2026

The Kidney Cancer Association's 'KCA Challenge: 81K Strong' once again demonstrated the incredible power of the kidney cancer community, raising $170,000 to support patients, caregivers, research and advocacy. The campaign, which kicked off Kidney Cancer Awareness Month on March 1st and finished on World Kidney Cancer Day June 18th, exceeded its fundraising goal of $81,000, set in honor of the approximately 81,000 individuals who will be diagnosed with kidney cancer this year.

AVEO Oncology, an LG Chem company, is proud to have been the sole sponsor of the 81K challenge by matching every dollar raised, up to $81,000, helping to double the impact of this remarkable fundraising effort that continues to accelerate kidney cancer research.

07/10/2026

The AVEO Oncology, an LG Chem company, team came together for a 'happy hour' celebration to recognize and thank Michael Bailey, as he retired from his leadership role as President and CEO after an exceptional tenure guiding the company.

Michael's vision and unwavering commitment helped shape AVEO into the organization it is today. While we'll certainly miss seeing him at the helm, we're grateful that he'll continue to support the company as a valued member of our Board of Directors.

Thank you, Michael, for your leadership, mentorship and the lasting impact you've made on our team and the patients we serve.

07/01/2026

AVEO Oncology, an LG Chem company, announces an exciting new chapter in its leadership. Effective June 30th, Michael Bailey will be retiring from the role of President and Chief Executive Officer following a distinguished tenure leading the company. Current Chief Commercial Officer Mike Ferraresso has been appointed President and Chief Executive Officer and will join the company's Board of Directors. Kevin Peacock, Senior Vice President of Marketing and Business Analytics, has also been named Chief Commercial Officer.

We extend our sincere gratitude to Michael Bailey for his outstanding leadership and lasting contributions to AVEO. Michael guided the company through a period of tremendous transformation, including the approval and commercialization of FOTIVDA® (tivozanib) and AVEO's strategic partnership with LG Chem. We are pleased that he will continue to support the company as a member of the Board of Directors, helping ensure a seamless leadership transition. Congratulations to Mike and Kevin on their new roles as we continue advancing our mission to bring meaningful therapies to people living with cancer. You can read the full details here:

Download PDF BOSTON, June 30, 2026 /PRNewswire/ — AVEO Pharmaceuticals, Inc., an LG Chem company, (“AVEO”), a biopharmaceutical company committed to providing differentiated solutions to improve cancer patients lives, announced today that, as part of a comprehensive succession planning proce...

06/24/2026

Our AVEO Oncology, an LG Chem company, team was proud to participate in the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago earlier this month. Thank you to ASCO for providing an important platform to learn about the latest emerging clinical research, targeted therapies, precision medicine and the future of cancer care. We appreciated the opportunity to connect with so many members of the oncology community and everyone who visited the AVEO booth to engage in conversations about the evolving oncology landscape.

06/19/2026

Today, AVEO Oncology, an LG Chem company, commemorates and the freedom of all African Americans. Join us as we reflect on the significance of this important day in history.

06/18/2026

AVEO Oncology, an LG Chem company, joins the International Kidney Cancer Coalition (IKCC) today in celebrating to recognize the global impact of . This year’s theme is kidney cancer and emotional wellbeing, as many patients experience emotional challenges throughout their cancer journey, yet don’t discuss them with their healthcare teams. The campaign seeks to provide resources to help patients start these conversations with their healthcare providers and empower them to take control of their holistic health. Click here to learn more: https://ikcc.org/world-kidney-cancer-day/

06/09/2026

AVEO Oncology, an LG Chem company, was proud to join the community at The Jimmy Fund this year in support of cancer research and patient care at Dana-Farber Cancer Institute. As part of our sponsorship, the AVEO team created a larger-than-life ice cream cone featuring “sprinkles”, or messages from employees sharing loved ones remembered, patients we honor, or reflections on why advancing care for people living with cancer is so meaningful to us. Thank you to everyone who stopped by and helped make this year’s Scooper Bowl another memorable (and sweet) success!

06/08/2026

We’re incredibly proud to see our President and CEO Michael Bailey featured in a recent OncoDaily profile highlighting his leadership journey. In the article, Michael reflects on a career spanning science, business, and oncology innovation, sharing insights on resilience, the importance of learning from setbacks, and keeping patients at the center of every decision. His perspective and unwavering commitment to improving outcomes for people living with cancer has helped shape the culture and mission at AVEO Oncology, an LG Chem company, as we continue to bring meaningful treatment options to patients and the healthcare professionals who care for them. Congratulations Michael on this well-deserved recognition! Read the full article here:https://oncodaily.com/magazine/michael-bailey-aveo-2026

Michael Bailey: Don’t take yourself too seriously / AVEO, Aveo Oncology, FOTIVDA, Michael Bailey, OncoDaily, OncoDaily Magazine, Oncology, Tivozanib